Table 6.
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Men | 1.322 | 0.744–2.350 | 0.342 | |||
Age | 1.011 | 0.986–1.037 | 0.386 | |||
Cirrhosis | 1.669 | 0.765–3.644 | 0.198 | |||
Hepatocellular carcinoma | 1.874 | 0.605–5.807 | 0.277 | |||
HBV DNA | 0.197 | 0.110–0.354 | < 0.001* | 0.283 | 0.146–0.550 | < 0.001* |
HBsAg | 0.148 | 0.093–0.237 | < 0.001* | 0.300 | 0.148–0.610 | < 0.001* |
HBeAg | 0.137 | 0.017–1.115 | 0.063 | |||
ALT | 1.003 | 0.994–1.013 | 0.478 | |||
AST | 1.001 | 0.993–1.008 | 0.882 | |||
ALP | 1.002 | 0.995–1.010 | 0.549 | |||
GGT | 1.003 | 0.997–1.010 | 0.325 | |||
TC | 1.194 | 0.917–1.554 | 0.188 | |||
TG | 1.547 | 1.167–2.051 | 0.002* | 1.142 | 0.647–2.017 | 0.647 |
BMI | 0.934 | 0.832–1.047 | 0.242 | |||
CAP values | 1.021 | 1.013–1.029 | < 0.001* | 1.013 | 1.001–1.026 | 0.038* |
LSM values | 1.020 | 0.978–1.063 | 0.361 |
OR Odds ratio, CI Confidence interval, ALT Alanine aminotransferase, AST Aspartate aminotransferase, ALP Alkaline phosphatase, GGT Gamma-glutamyltransferase, TC Total cholesterol, TG Triacylglycerol, BMI Body mass index, CAP Controlled attenuation parameter, LSM Liver stiffness measurement
*Statistically significant at P < 0.05